Reflections on the Gene Patent War: The Myriad Battle, Sputnik and BeyondCAULFIELD, Timothy.Clinical chemistry (Baltimore, Md.). 2011, Vol 57, Num 7, pp 977-979, issn 0009-9147, 3 p.Article

Biotechnology and the popular press: hype and the selling of scienceCAULFIELD, Timothy.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 7, pp 337-339, issn 0167-7799, 3 p.Article

From human genes to stem cells: new challenges for patent law?CAULFIELD, Timothy A.Trends in biotechnology (Regular ed.). 2003, Vol 21, Num 3, pp 101-103, issn 0167-7799, 3 p.Article

International policy failures: cloning and stem-cell research. CommentaryTAUER, Carol A; CAULFIELD, Timothy.Lancet (British edition). 2004, Vol 364, Num 9429, pp 124-126, issn 0140-6736, 9 p.Article

Role and reality: technology transfer at Canadian universitiesBUBELA, Tania M; CAULFIELD, Timothy.Trends in biotechnology (Regular ed.). 2010, Vol 28, Num 9, pp 447-451, issn 0167-7799, 5 p.Article

Human dignity : a guide to policy making in the biotechnology era?CAULFIELD, Timothy; BROWNSWORD, Roger.Nature reviews. Genetics (Print). 2006, Vol 7, Num 1, pp 72-76, issn 1471-0056, 5 p.Article

Gene patents, health care policy and licensing schemesCAULFIELD, Timothy; VON TIGERSTROM, Barbara.Trends in biotechnology (Regular ed.). 2006, Vol 24, Num 6, pp 251-254, issn 0167-7799, 4 p.Article

Profile. CommentaryPIRISI, Angela; CAULFIELD, Timothy.Lancet (British edition). 2004, Vol 364, Num 9429, pp 124-126, issn 0140-6736, 3 p., 133 [4 p.]Article

Canadian Newspaper Coverage of the A/H1N1 Vaccine ProgramRACHUL, Christen M; RIES, Nola M; CAULFIELD, Timothy et al.Canadian journal of public health. 2011, Vol 102, Num 3, pp 200-203, issn 0008-4263, 4 p.Article

Research ethics and the challenge of whole-genome sequencingMCGUIRE, Amy L; CAULFIELD, Timothy; CHO, Mildred K et al.Nature reviews. Genetics (Print). 2008, Vol 9, Num 2, pp 152-156, issn 1471-0056, 5 p.Article

Direct-to-consumer testing: if consumers are not anxious, why are policymakers?CAULFIELD, Timothy.Human genetics. 2011, Vol 130, Num 1, pp 23-25, issn 0340-6717, 3 p.Article

The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnologyGOLD, E. Richard; CAULFIELD, Timothy A.Lancet (British edition). 2002, Vol 359, Num 9325, pp 2268-2270, issn 0140-6736Article

Trust, patents and public perceptions : the governance of controversial biotechnology researchCAULFIELD, Timothy; EINSIEDEL, Edna; MERZ, Jon F et al.Nature biotechnology. 2006, Vol 24, Num 11, pp 1352-1354, issn 1087-0156, 3 p.Article

The Challenge of Regulating Rapidly Changing Science: Stem Cell Legislation in CanadaRUGG-GUNN, Peter J; OGBOGU, Ubaka; ROSSANT, Janet et al.Cell stem cell. 2009, Vol 4, Num 4, pp 285-288, issn 1934-5909, 4 p.Article

Financial Incentives to Increase Canadian Organ Donation: Quick Fix or Fallacy?GILL, John S; KLARENBACH, Scott; BARNIEH, Lianne et al.American journal of kidney diseases. 2014, Vol 63, Num 1, pp 133-140, issn 0272-6386, 8 p.Article

Restricting marketing to children: Consensus on policy interventions to address obesityRAINE, Kim D; LOBSTEIN, Tim; LANDON, Jane et al.Journal of public health policy. 2013, Vol 34, Num 2, pp 239-253, issn 0197-5897, 15 p.Article